Serum GM-CSF autoantibody tests were negative (Figure S3H), ruling out autoimmune PAP; negative genetic testing ruled out congenital PAP (Table S1); and absence of pulmonary exposures or other underlying PAP-causing conditions ruled out secondary PAP. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.